Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
L-Canavanine is a non-proteinogenic amino acid primarily found in leguminous plants such as alfalfa (Medicago sativa), where it serves as a defensive allelochemical against herbivores. [1] It is a structural analog of the essential amino acid L-arginine, distinguished by the replacement of the terminal methylene group with an oxygen atom. [2] This structural similarity allows L-canavanine to act as a potent antimetabolite by competing with L-arginine for transport and enzymatic utilization. [3] A significant biological consequence of this competition is the mistaken incorporation of L-canavanine into nascent polypeptide chains by arginyl-tRNA synthetase, resulting in the production of 'canavanyl-proteins' that are frequently misfolded and dysfunctional. [4] Research has also identified L-canavanine as an inhibitor of nitric oxide synthase (NOS), particularly the inducible isoform (iNOS), suggesting potential therapeutic applications in inflammatory diseases and oncology. [5] However, its clinical development is strictly limited by its well-documented association with the induction or exacerbation of systemic lupus erythematosus (SLE) in humans and primates following the consumption of alfalfa seeds or sprouts. [6]
Competitively inhibits arginyl-tRNA synthetase leading to the incorporation of canavanine into proteins in place of arginine, and potently inhibits nitric oxide synthase (NOS).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on L-Canavanine.